Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Molecular Neurodegeneration|May 30, 2024
Single-domain antibody-based protein degrader for synucleinopathiesYixiang Jiang, Yan Lin, Amber M Tetlow, et al.
Cancer Treatment Reports|July 1, 1984
Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group studyR J Ignoffo, M A Friedman, M Gribble, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Single-Domain Antibody-Based Protein Degrader for SynucleinopathiesYixiang Jiang, Yan Lin, Amber M Tetlow, et al.
Neurobiology of Disease|November 9, 2020
Increased neuronal activity in motor cortex reveals prominent calcium dyshomeostasis in tauopathy miceQian Wu, Yang Bai, Wei Li, et al.
Urology|February 1, 1985
Testicular gonadal stromal (Sertoli cell) tumorM I Okoye, W F Mueller, C Y Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trialC A Russell, S J Green, J O'Sullivan, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 2, 2013
Neural substrates of inhibitory control deficits in 22q11.2 deletion syndromeC A Montojo, M Jalbrzikowski, E Congdon, et al.
Neuroimage. Clinical|October 29, 2015
Neural mechanisms of response inhibition and impulsivity in 22q11.2 deletion carriers and idiopathic attention deficit hyperactivity disorderC A Montojo, E Congdon, L Hwang, et al.
BMC Cancer|January 19, 2021
"SQiD, the Single Question in Delirium; can a single question help clinicians to detect delirium in hospitalised cancer patients?" running heading Single Question in Delirium" (Bcan-D-20-01665)Megan B Sands, Swapnil Sharma, Lindsay Carpenter, et al.
Ebiomedicine|September 13, 2022
Single domain antibodies targeting pathological tau protein: Influence of four IgG subclasses on efficacy and toxicityErin E Congdon, Ruimin Pan, Yixiang Jiang, et al.
Pageof 6